Error: Could not add to watchlist. X

Elan Corp PLC

+ Watchlist
ELN:ID
Acquired
ELN:ID was acquired by PRGO:US
EUR
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (EUR) (TTM)
-0.01
Market Cap (EUR)
-
Shares Outstanding (m)
515.712
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Elan Corporation plc is a specialty pharmaceutical company. The Group's drug delivery technologies are designed to aid and control the absorption and utilization of active pharmaceutical compounds. Elan's Pharmaceutical division focuses on the discovery, development and commercialization of products in the areas of acute care, pain management, infectious diseases and neurology.
ADDRESS
Lower Grand Canal Street
Treasury Building
Dublin 2
Ireland
PHONE
353-1-709-4000
  • Hans Peter Hasler
    Chief Operating Officer
  • Fabiana Lacerca-Allen
    Chief Compliance Officer
  • Guriq Basi
    Chief Science & Tech Officer
  • Menghis Bairu
    Exec VP/Chief Medical Officer
  • Chris Burns
    Senior VP:Investor Relations
Show More